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Introduction
Microsomal prostaglandin E2 Synthase (mPGES)-1 cata-
lyzes the terminal step in the biosynthesis of PGE2.
Early growth response factor-1 (Egr-1) is a key tran-
scription factor in the regulation of mPGES-1. In the
present study we examined the effects of valproic acid
(VA), a histone deacetylase (HDAC) inhibitor, on inter-
leukin (IL)-1b-induced mPGES-1-expression in human
chondrocytes.
Methods
Chondrocytes were stimulated with IL-1 in the absence
or presence of VA, and the level of mPGES-1 protein
and mRNA expression were evaluated using Western
blotting and real-time reverse-transcription polymerase
chain reaction, respectively. The mPGES-1 promoter
activity was analyzed in transient transfection experi-
ments. Egr-1 recruitment to the mPGES-1 promoter
were evaluated using chromatin immunoprecipitation
(ChIP) assays.
Results
VA dose-dependently suppressed IL-1b-induced
mPGES-1 protein and mRNA expression as well as its
promoter activation. Treatment with VA did not alter
IL-1-induced Egr-1 expression, nor its recruitment to
the mPGES-1 promoter, but prevented its transcrip-
tional activity.
Conclusion
Our study demonstrates that VA inhibits IL-1-induced
mPGES-1 expression in chondrocytes. The suppressive
effect of VA was not due to reduced expression or
recruitment of Egr-1 to the mPGES-1 promoter.
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